New Advances in Pharmacology of Gout
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Sayed, Bayan Yassin Z | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Kenézy Kórház Aneszteziológiai és Intenziv Therápiás Osztály | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.date.accessioned | 2017-01-12T12:13:57Z | |
| dc.date.available | 2017-01-12T12:13:57Z | |
| dc.date.created | 2016 | |
| dc.description.abstract | Gout is the most common inflammatory arthrits, where severe Pain and swelling develops in the joints. characterized by deposition of Mono sodium urate crystals.In spite of being the most well known inflammatory arthritis Gout is frequently inadequately managed. Several agents are currently underdevelopment. Expanding information's with respect to renal urate transporters has brought about the advancement of new era Uricosurics, for example : Lesinurad and Arhalofenate. | hu_HU |
| dc.description.corrector | tben | |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 36 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/233988 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Pharmacological Treatment | hu_HU |
| dc.subject | Gout | |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | New Advances in Pharmacology of Gout | hu_HU |